ArticleFrontiers in microbiology2026
Detection and quantification of membrane-damaging antimicrobials using pHluorin2-based bacterial biosensors.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteriocins are ribosomally synthesized antimicrobial peptides of bacterial origin. Many known bacteriocins kill susceptible bacteria by interacting with cell surface receptors and disrupting membrane integrity, leading to the collapse of pH homeostasis. The fluorescent protein pHluorin2 is a GFP-derivative characterized by two distinct excitation peaks at 400 and 475 nm that change in relative fluorescence intensities in a ratiometric manner in response to changes in pH. Bacteria expressing pHluorin2 show fluorescence profiles characteristic for their intracellular pH. When placed in buffer at a pH that is different from the intracellular pH by ±1-2 units, these bacteria are able to maintain pH homeostasis. However, when treated with compounds that disrupt membrane integrity such as many bacteriocins, the intracellular pH rapidly changes to the pH of the buffer resulting in a change in the fluorescence profile of pHluorin2 within seconds. This change can be assessed with any method that is able to detect fluorescence intensities at the two excitation maxima of the protein. Hence, pHluorin2-expressing bacteria can be used to measure the activity of membrane-damaging antimicrobials by orders of magnitude faster than with conventional, growth-dependent assays. The methods presented here describe construction and use of live biosensor bacteria that express pHluorin2 for investigation of membrane-damaging compounds such as bacteriocins. Applications of these biosensors include characterization, screening, and quantification by various methods comprising spectrophotometry in microtiter plate readers, microscopy, and flow cytometry. Additionally, the protocol introduces a procedure for preparation of ready-to-use assay plates with freeze-dried pHluorin2 biosensor bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.